Nature Communications · 2018 · 233 citations · 47 references
MedicineCell BiologyOncologyCell SignalingMolecular OncologySignal TransductionAngiogenesisAngiogenesis In CancerCancer Cell SignalingExtracellular Vesicle SignalingOvarian CancerSignal Transduction In CancerAngiogenic BiomarkersExosomal BiomarkersExosomesExosomes In CancerMalignant AscitesPeritoneal DisseminationTumor Angiogenesis SignalingTumor-derived Exosomes
The limitations of current anti-angiogenic therapies necessitate other targets with complimentary mechanisms. Here, we show for the first time that soluble E-cadherin (sE-cad) (an 80-kDa soluble form), which is highly expressed in the malignant ascites of ovarian cancer patients, is a potent inducer of angiogenesis. In addition to ectodomain shedding, we provide further evidence that sE-cad is abundantly released in the form of exosomes. Mechanistically, sE-cad-positive exosomes heterodimerize with VE-cadherin on endothelial cells and transduce a novel sequential activation of β-catenin and NFκB signaling. In vivo and clinical data prove the relevance of sE-cad-positive exosomes for malignant ascites formation and widespread peritoneal dissemination. These data advance our understanding of the molecular regulation of angiogenesis in ovarian cancer and support the therapeutic potential of targeting sE-cad. The exosomal release of sE-cad, which represents a common route for externalization in ovarian cancer, could potentially be biomarkers for diagnosis and prognosis.
47
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa‐Silva, Nicole M. Aiello, Allyson J. Ocean et al. · Nature Cell Biology · 2015 · 2.7K citations · Full text
Medicine, Cancer Biology, Oncology +14
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Joseph Wolfers, Anne Lozier, Graça Raposo et al. · Nature Medicine · 2001 · 1.6K citations
Life Sciences, Immunology, Oncology +16